7731 - 7740 of 9038 Results
Title
Year
- A randomized clinical trial of burst vs. spaced physical therapy for Parkinsons disease2022RESTRICTEDTitle: A randomized clinical trial of burst vs. spaced physical therapy for Parkinsons diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 57End Page: 62Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.021Citation Count: 12
- Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension2022RESTRICTEDTitle: Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotensionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 99Issue #:Start Page: 62End Page: 64Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.002Citation Count: 3
- Smoking is associated with age at disease onset in Parkinson's disease2022RESTRICTEDTitle: Smoking is associated with age at disease onset in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 79End Page: 83Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.03.005Citation Count: 6
- Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's disease2021RESTRICTEDTitle: Combined 5-HT2A and mGlu2 modulation for the treatment of dyskinesia and psychosis in Parkinson's diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 186Issue #:Start Page: 108465End Page: 108465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108465Citation Count: 19
- Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's disease2022RESTRICTEDTitle: Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 99Issue #:Start Page: 58End Page: 61Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.010Citation Count: 21
-
OPENTitle: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 196Issue #:Start Page: 108693End Page: 108693Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693Best OA location URL: https://hdl.handle.net/11584/325357Citation Count: 26
- Special Issue on new therapeutic approaches to Parkinson disease2022RESTRICTEDTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Citation Count: 5
-
OPENTitle: Spontaneous changes in brain striatal dopamine synthesis and storage dynamics ex vivo reveal end-product feedback-inhibition of tyrosine hydroxylaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 212Issue #:Start Page: 109058End Page: 109058Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109058Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109058Citation Count: 9
-
OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 11
-
OPENTitle: Biomarkers and non-motor symptoms as a function of motor symptom asymmetry in early Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 177Issue #:Start Page: 108419End Page: 108419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108419Best OA location URL: https://doi.org/10.1016/j.neuropsychologia.2022.108419Citation Count: 20